204 related articles for article (PubMed ID: 23437409)
1. T cell hypo-responsiveness against Leishmania major in MAP kinase phosphatase (MKP) 2 deficient C57BL/6 mice does not alter the healer disease phenotype.
Schroeder J; McGachy HA; Woods S; Plevin R; Alexander J
PLoS Negl Trop Dis; 2013; 7(2):e2064. PubMed ID: 23437409
[TBL] [Abstract][Full Text] [Related]
2. MAP kinase phosphatase-2 plays a critical role in response to infection by Leishmania mexicana.
Al-Mutairi MS; Cadalbert LC; McGachy HA; Shweash M; Schroeder J; Kurnik M; Sloss CM; Bryant CE; Alexander J; Plevin R
PLoS Pathog; 2010 Nov; 6(11):e1001192. PubMed ID: 21085614
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 Responsive Dendritic Cells Are Dispensable to Host Resistance Against
Osero BO; Cele Z; Aruleba RT; Maine RA; Ozturk M; Lutz MB; Brombacher F; Hurdayal R
Front Immunol; 2021; 12():759021. PubMed ID: 35154068
[TBL] [Abstract][Full Text] [Related]
4. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
[TBL] [Abstract][Full Text] [Related]
5. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
Rodríguez-Sosa M; Rivera-Montoya I; Espinoza A; Romero-Grijalva M; López-Flores R; González J; Terrazas LI
Cell Immunol; 2006 Aug; 242(2):61-71. PubMed ID: 17118349
[TBL] [Abstract][Full Text] [Related]
6. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.
Srivastava N; Sudan R; Saha B
J Immunol; 2011 May; 186(10):5863-72. PubMed ID: 21471446
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
8. PKCδ regulates IL-12p40/p70 production by macrophages and dendritic cells, driving a type 1 healer phenotype in cutaneous leishmaniasis.
Guler R; Afshar M; Arendse B; Parihar SP; Revaz-Breton M; Leitges M; Schwegmann A; Brombacher F
Eur J Immunol; 2011 Mar; 41(3):706-15. PubMed ID: 21287553
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
[TBL] [Abstract][Full Text] [Related]
10. MAP kinase phosphatase-2 plays a key role in the control of infection with Toxoplasma gondii by modulating iNOS and arginase-1 activities in mice.
Woods S; Schroeder J; McGachy HA; Plevin R; Roberts CW; Alexander J
PLoS Pathog; 2013 Aug; 9(8):e1003535. PubMed ID: 23966857
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
Li J; Nolan TJ; Farrell JP
Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
Webb JR; Kaufmann D; Campos-Neto A; Reed SG
J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
[TBL] [Abstract][Full Text] [Related]
13. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection.
Satoskar A; Bluethmann H; Alexander J
Infect Immun; 1995 Dec; 63(12):4894-9. PubMed ID: 7591152
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Leishmanization Using
Keshavarzian N; Noroozbeygi M; Haji Molla Hoseini M; Yeganeh F
Front Immunol; 2020; 11():1725. PubMed ID: 33193290
[No Abstract] [Full Text] [Related]
15. Both the Fas ligand and inducible nitric oxide synthase are needed for control of parasite replication within lesions in mice infected with Leishmania major whereas the contribution of tumor necrosis factor is minimal.
Chakour R; Guler R; Bugnon M; Allenbach C; Garcia I; Mauël J; Louis J; Tacchini-Cottier F
Infect Immun; 2003 Sep; 71(9):5287-95. PubMed ID: 12933876
[TBL] [Abstract][Full Text] [Related]
16. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of
Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C
Front Immunol; 2018; 9():79. PubMed ID: 29459858
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils have a protective role during early stages of Leishmania amazonensis infection in BALB/c mice.
Sousa LM; Carneiro MB; Resende ME; Martins LS; Dos Santos LM; Vaz LG; Mello PS; Mosser DM; Oliveira MA; Vieira LQ
Parasite Immunol; 2014 Jan; 36(1):13-31. PubMed ID: 24102495
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
Iborra S; Soto M; Carrión J; Alonso C; Requena JM
Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
[TBL] [Abstract][Full Text] [Related]
19. The role of IL-10 in promoting disease progression in leishmaniasis.
Kane MM; Mosser DM
J Immunol; 2001 Jan; 166(2):1141-7. PubMed ID: 11145695
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
Erb KJ; Blank C; Moll H
Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
